"Receptors, Interleukin-2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.
Descriptor ID |
D015375
|
MeSH Number(s) |
D12.776.543.750.705.852.420.320
|
Concept/Terms |
Receptors, Interleukin-2- Receptors, Interleukin-2
- Receptors, Interleukin 2
- TCGF Receptor
- TCGF Receptors
- Receptors, TCGF
- IL-2 Receptor
- IL 2 Receptor
- Receptor, IL-2
- IL-2 Receptors
- IL 2 Receptors
- T-Cell Growth Factor Receptor
- T Cell Growth Factor Receptor
- IL2 Receptors
- Receptors, IL2
- Interleukin 2 Receptor
- Receptor, Interleukin 2
- Interleukin-2 Receptors
- Interleukin 2 Receptors
- Receptor, TCGF
- Receptors, IL-2
- Receptors, IL 2
- Receptors, T-Cell Growth Factor
- Receptors, T Cell Growth Factor
- T-Cell Growth Factor Receptors
- T Cell Growth Factor Receptors
- IL2 Receptor
- Receptor, IL2
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-2".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-2".
This graph shows the total number of publications written about "Receptors, Interleukin-2" by people in this website by year, and whether "Receptors, Interleukin-2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
1999 | 1 | 3 | 4 |
2003 | 1 | 1 | 2 |
2004 | 0 | 2 | 2 |
2005 | 1 | 1 | 2 |
2006 | 2 | 2 | 4 |
2008 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2016 | 0 | 2 | 2 |
2017 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Interleukin-2" by people in Profiles.
-
Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging. Int Heart J. 2021 Sep 30; 62(5):1096-1105.
-
Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant Recipients Maintained on Tacrolimus: A Systematic Review and Meta-Analysis. Am J Nephrol. 2021; 52(4):279-291.
-
Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis. Int Urol Nephrol. 2020 Apr; 52(4):791-802.
-
Cytomegalovirus-Induced Hemophagocytic Lymphohistiocytosis in an Extreme Preterm Infant: Recognition and Therapy Leading to Recovery. Adv Neonatal Care. 2017 Apr; 17(2):91-95.
-
Yes, We Still Need IL-2 Receptor Antagonists. Am J Transplant. 2016 11; 16(11):3308-3309.
-
Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching. Exp Clin Transplant. 2017 Feb; 15(1):47-55.
-
Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg. 2014 May; 259(5):888-93.
-
Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells. Proc Natl Acad Sci U S A. 2010 Jun 29; 107(26):11906-11.
-
Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. Transplant Proc. 2008 Dec; 40(10):3401-7.
-
IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response. Blood. 2008 Nov 01; 112(9):3704-12.